Journal of Antimicrobial Chemotherapy (2002) 50, 25-31
© 2002 The British Society for Antimicrobial Chemotherapy
Two novel assays for the detection of haemin-binding properties of antimalarials evaluated with compounds isolated from medicinal plants
1 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT; 2 Royal Botanic Gardens, Kew, Richmond, Surrey TW9 3AB, UK
Received 30 August 2001; returned 16 January 2002; revised 21 February 2002; accepted 18 April 2002
Forty-two compounds isolated from nine plants used within South America for the treatment of malaria were tested for haemin binding using two novel, rapid screening methods. The data obtained were analysed with respect to IC50 values for in vitro toxicity to Plasmodium falciparum trophozoites. One method, a multiwell assay based on the inhibition of the interaction of haemin with glutathione (GSH), is sensitive in the 10 µM range, takes c. 1 h and is suitable for either a high throughput screen or rapid assay during natural product isolation. Of 19 compounds showing antiplasmodial activity (IC50 < 40 µM), 16 (84%) showed >40% inhibition of GSH–haemin reaction. The sensitivity and specificity of the assay were 0.85 and 0.82, respectively. The positive predictive value was 0.81 and the negative predictive value 0.86. A more sensitive assay (0.1 µM range) is based on the reversal by haemin-binding compounds of the haemin inhibition of the L-dopachrome-methyl ester tautomerase activity of human macrophage migration inhibitory factor. This assay gives a better idea of the affinity of interaction and uses very small amounts of test compound. The log[RI50] of eight of the compounds that tested positive in the above assays together with those of quinine and chloroquine showed a positive correlation with log[antiplasmodial IC50] for strain T9-96 (r = 0.824) and strain K1 (r = 0.904). Several of the antimalarial compounds that bind haemin are isoquinolines, a class not shown previously to interact with haemin.
* Corresponding author. Tel: +44-20-7612-7865; Fax +44-20-7636-8739; E-mail: david.meyer{at}lshtm.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. R. Smyth, A. Barbato, N. Beydon, H. Bisgaard, K. de Boeck, P. Brand, A. Bush, B. Fauroux, J. de Jongste, M. Korppi, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities Eur. Respir. J., February 1, 2010; 35(2): 247 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Furuie, Y. Saisho, T. Yoshikawa, and J. Shimada Intrapulmonary Pharmacokinetics of S-013420, a Novel Bicyclolide Antibacterial, in Healthy Japanese Subjects Antimicrob. Agents Chemother., February 1, 2010; 54(2): 866 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Martin, S. Quilici, T. File, J. Garau, A. Kureishi, and M. Kubin Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance J. Antimicrob. Chemother., May 1, 2007; 59(5): 977 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Isozumi, Y. Ito, T. Ishida, M. Osawa, T. Hirai, I. Ito, K. Maniwa, M. Hayashi, H. Kagioka, M. Hirabayashi, et al. Genotypes and Related Factors Reflecting Macrolide Resistance in Pneumococcal Pneumonia Infections in Japan J. Clin. Microbiol., May 1, 2007; 45(5): 1440 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Hawkyard and R. J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Butler, W. A. LaMarr, K. A. Foster, M. H. Barnes, D. J. Skow, P. T. Lyden, L. M. Kustigian, C. Zhi, N. C. Brown, G. E. Wright, et al. Antibacterial Activity and Mechanism of Action of a Novel Anilinouracil-Fluoroquinolone Hybrid Compound Antimicrob. Agents Chemother., January 1, 2007; 51(1): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Y. Fukushima, Y. Hirakata, K. Sugahara, K. Yanagihara, A. Kondo, S. Kohno, and S. Kamihira Rapid Screening of Topoisomerase Gene Mutations by a Novel Melting Curve Analysis Method for Early Warning of Fluoroquinolone-Resistant Streptococcus pneumoniae Emergence J. Clin. Microbiol., December 1, 2006; 44(12): 4553 - 4558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Coenen, M. Ferech, S. Malhotra-Kumar, E. Hendrickx, C. Suetens, H. Goossens, and on behalf of the ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe J. Antimicrob. Chemother., August 1, 2006; 58(2): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Faccone, P. Andres, M. Galas, M. Tokumoto, A. Rosato, and A. Corso Emergence of a Streptococcus pneumoniae Clinical Isolate Highly Resistant to Telithromycin and Fluoroquinolones J. Clin. Microbiol., November 1, 2005; 43(11): 5800 - 5803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Sun, S. Y. Lee, M. A. Banevicius, X. Du, D. Maglio, and D. P. Nicolau Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model J. Antimicrob. Chemother., September 1, 2005; 56(3): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert, M. van der Linden, and A. Al-Lahham Molecular Characterization of the First Telithromycin-Resistant Streptococcus pneumoniae Isolate in Germany Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3520 - 3522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert, S. Reinert, M. van der Linden, M. Y. Cil, A. Al-Lahham, and P. Appelbaum Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003 Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2903 - 2913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Frolich, C. Schubert, U. Bienzle, and K. Jenett-Siems In vitro antiplasmodial activity of prenylated chalcone derivatives of hops (Humulus lupulus) and their interaction with haemin J. Antimicrob. Chemother., June 1, 2005; 55(6): 883 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Littauer, M. Sangvik, D. A. Caugant, E. A. Hoiby, G. S. Simonsen, A. Sundsfjord, and the Norwegian Macrolide Study Group Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway J. Clin. Microbiol., May 1, 2005; 43(5): 2125 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Halpern, J. K. Schmier, L. M. Snyder, C. Asche, P. W. Sarocco, B. Lavin, R. Nieman, and L. A. Mandell Meta-analysis of bacterial resistance to macrolides J. Antimicrob. Chemother., May 1, 2005; 55(5): 748 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. M. Jimenez, J. L. M. Bellido, and J. A. Garcia Rodriguez Risk Factors Associated with Colonization by Pneumococci with Reduced Susceptibility to Fluoroquinolones in Adult Outpatients J. Clin. Microbiol., March 1, 2005; 43(3): 1193 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nunes, R. Sa-Leao, J. Carrico, C. R. Alves, R. Mato, A. B. Avo, J. Saldanha, J. S. Almeida, I. S. Sanches, and H. de Lencastre Trends in Drug Resistance, Serotypes, and Molecular Types of Streptococcus pneumoniae Colonizing Preschool-Age Children Attending Day Care Centers in Lisbon, Portugal: a Summary of 4 Years of Annual Surveillance J. Clin. Microbiol., March 1, 2005; 43(3): 1285 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert, A. Ringelstein, M. van der Linden, M. Y. Cil, A. Al-Lahham, and F.-J. Schmitz Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe J. Clin. Microbiol., March 1, 2005; 43(3): 1294 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Morrissey, M. Robbins, L. Viljoen, and D. F. J. Brown Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods J. Antimicrob. Chemother., February 1, 2005; 55(2): 200 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bruinsma, K. G. Kristinsson, S. Bronzwaer, P. Schrijnemakers, J. Degener, E. Tiemersma, W. Hryniewicz, J. Monen, H. Grundmann, and on behalf of EARSS participants Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe J. Antimicrob. Chemother., December 1, 2004; 54(6): 1045 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Birtles, N. Virgincar, C. L Sheppard, R. A Walker, A. P Johnson, M. Warner, V. Edwards-Jones, and R. C George Antimicrobial resistance of invasive Streptococcus pneumoniae isolates in a British district general hospital: the international connection J. Med. Microbiol., December 1, 2004; 53(12): 1241 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Brown, D. J. Farrell, and I. Morrissey Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study J. Clin. Microbiol., November 1, 2004; 42(11): 4980 - 4987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D J Farrell, S G Jenkins, and R R Reinert Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators J. Med. Microbiol., November 1, 2004; 53(11): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Powis, A. McGeer, K. Green, O. Vanderkooi, K. Weiss, G. Zhanel, T. Mazzulli, M. Kuhn, D. Church, R. Davidson, et al. In Vitro Antimicrobial Susceptibilities of Streptococcus pneumoniae Clinical Isolates Obtained in Canada in 2002 Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3305 - 3311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Felmingham, J. Shackcloth, and G. Tillotson BSAC Respiratory Resistance Surveillance Programme (2002-2003): comparative susceptibility of Streptococcus pneumoniae, cultured from patients in Great Britain and Ireland with community-acquired lower respiratory tract infection, to gemifloxacin J. Antimicrob. Chemother., September 1, 2004; 54(3): 698 - 699. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A Goff Short-Duration Therapy for Respiratory Tract Infections Ann. Pharmacother., September 1, 2004; 38(9_suppl): S19 - S23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kresken, B. Henrichfreise, S. Bagel, J. Brauers, and B. Wiedemann High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3193 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tellier, M. S. Niederman, R. Nusrat, M. Patel, and B. Lavin Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia J. Antimicrob. Chemother., August 1, 2004; 54(2): 515 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert Clinical efficacy of ketolides in the treatment of respiratory tract infections J. Antimicrob. Chemother., June 1, 2004; 53(6): 918 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell and D. Felmingham Activities of Telithromycin against 13,874 Streptococcus pneumoniae Isolates Collected between 1999 and 2003 Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1882 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Morrissey and G. Tillotson Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae J. Antimicrob. Chemother., February 1, 2004; 53(2): 144 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Muller-Serieys, J. Andrews, F. Vacheron, and C. Cantalloube Tissue kinetics of telithromycin, the first ketolide antibacterial J. Antimicrob. Chemother., February 1, 2004; 53(2): 149 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Dandliker, S. D. Pratt, A. M. Nilius, C. Black-Schaefer, X. Ruan, D. L. Towne, R. F. Clark, E. E. Englund, R. Wagner, M. Weitzberg, et al. Novel Antibacterial Class Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3831 - 3839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Saha, A. H. Baqui, G. L. Darmstadt, M. Ruhulamin, M. Hanif, S. El Arifeen, M. Santosham, K. Oishi, T. Nagatake, and R. E. Black Comparison of Antibiotic Resistance and Serotype Composition of Carriage and Invasive Pneumococci among Bangladeshi Children: Implications for Treatment Policy and Vaccine Formulation J. Clin. Microbiol., December 1, 2003; 41(12): 5582 - 5587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Waites, K. E. Jones, K. H. Kim, S. A. Moser, C. N. Johnson, S. K. Hollingshead, E.-S. Kang, K. S. Hong, and W. H. Benjamin Jr. Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea J. Clin. Microbiol., December 1, 2003; 41(12): 5787 - 5791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Johnson, C. L. Sheppard, S. J. Harnett, A. Birtles, T. Harrison, N. P. Brenwald, M. J. Gill, R. A. Walker, D. M. Livermore, and R. C. George Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England J. Antimicrob. Chemother., December 1, 2003; 52(6): 953 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Buxbaum, S. Forsthuber, W. Graninger, and A. Georgopoulos Comparative activity of telithromycin against typical community-acquired respiratory pathogens J. Antimicrob. Chemother., September 1, 2003; 52(3): 371 - 374. [Abstract] [Full Text] [PDF]
|
|